Published in Drug Alcohol Rev on July 01, 2017
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Effects of a sustained heroin shortage in three Australian States. Addiction (2005) 6.62
The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction (2010) 5.14
The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction (2003) 4.92
The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res (2003) 3.72
Alcohol as a risk factor for global burden of disease. Eur Addict Res (2003) 3.11
Surveying the range and magnitude of alcohol's harm to others in Australia. Addiction (2011) 2.80
Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev (2008) 2.72
Changes in volume of drinking after changes in alcohol taxes and travellers' allowances: results from a panel study. Addiction (2007) 2.55
The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health (2009) 2.39
Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev (2006) 2.33
Changing the density of alcohol outlets to reduce alcohol-related problems. Drug Alcohol Rev (2007) 2.17
Local government alcohol policy development: case studies in three New Zealand communities. Addiction (2012) 2.13
Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust (2005) 2.11
Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs. Drug Alcohol Rev (2012) 2.06
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction (2009) 2.03
Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction (2007) 1.92
Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health (2011) 1.81
The oral health of street-recruited injecting drug users: prevalence and correlates of problems. Addiction (2008) 1.71
Multi-level analysis of causal attribution of injury to alcohol and modifying effects: Data from two international emergency room projects. Drug Alcohol Depend (2005) 1.49
International regulation of alcohol. BMJ (2008) 1.48
Drinking patterns and their gender differences in Europe. Alcohol Alcohol Suppl (2006) 1.48
Alcohol's involvement in recurrent child abuse and neglect cases. Addiction (2012) 1.47
"Let's get Wasted!" and Other Apps: Characteristics, Acceptability, and Use of Alcohol-Related Smartphone Applications. JMIR Mhealth Uhealth (2013) 1.40
Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol (2005) 1.39
Prohibition of cannabis. BMJ (2010) 1.38
Alcoholics anonymous careers: patterns of AA involvement five years after treatment entry. Alcohol Clin Exp Res (2005) 1.36
Method for moderation: measuring lifetime risk of alcohol-attributable mortality as a basis for drinking guidelines. Int J Methods Psychiatr Res (2008) 1.35
Alcohol-related negative consequences among drinkers around the world. Addiction (2011) 1.33
The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ (2007) 1.32
Surveying alcohol and other drug use through telephone sampling: a comparison of landline and mobile phone samples. BMC Med Res Methodol (2013) 1.32
Methamphetamine use, aggressive behavior and other mental health issues among high-school students in Cape Town, South Africa. Drug Alcohol Depend (2010) 1.26
Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction (2009) 1.22
Alcohol and infectious diseases: an overlooked causal linkage? Addiction (2009) 1.21
The relationship between self-reported drinking and BAC level in emergency room injury cases: is it a straight line? Alcohol Clin Exp Res (2010) 1.16
Mapping Australian public opinion on alcohol policies in the new millennium. Drug Alcohol Rev (2009) 1.15
Validity of self-reported drinking before injury compared with a physiological measure: cross-national analysis of emergency-department data from 16 countries. J Stud Alcohol Drugs (2007) 1.14
Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction (2007) 1.12
Changes in alcohol-related problems after alcohol policy changes in Denmark, Finland, and Sweden. J Stud Alcohol Drugs (2010) 1.11
The importance of environmental modifiers of the relationship between substance use and harm. Addiction (2004) 1.10
Non-response bias in a community survey of drinking, alcohol-related experiences and public opinion on alcohol policy. Drug Alcohol Depend (2012) 1.09
Disability associated with alcohol abuse and dependence. Alcohol Clin Exp Res (2010) 1.08
Heavy stimulant use remains a significant health concern for Australia. Med J Aust (2011) 1.07
Constructing and responding to low-risk drinking guidelines: conceptualisation, evidence and reception. Drug Alcohol Rev (2012) 1.07
Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization. Addiction (2010) 1.06
Warnings on alcohol containers and advertisements: international experience and evidence on effects. Drug Alcohol Rev (2009) 1.05
Diverging trends in alcohol consumption and alcohol-related harm in Victoria. Aust N Z J Public Health (2010) 1.04
Variations by age and sex in alcohol-related problematic behaviour per drinking volume and heavier drinking occasion. Drug Alcohol Depend (2009) 1.04
Intranasal naloxone for the treatment of suspected heroin overdose. Addiction (2008) 1.04
Individual and community correlates of young people's high-risk drinking in Victoria, Australia. Drug Alcohol Depend (2008) 1.03
Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results. Harm Reduct J (2013) 1.02
Determination of lifetime injury mortality risk in Canada in 2002 by drinking amount per occasion and number of occasions. Am J Epidemiol (2008) 1.01
Attribution of alcohol to violence-related injury: self and other's drinking in the event. J Stud Alcohol Drugs (2012) 1.01
Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction (2008) 0.99
Extending drug ethno-epidemiology using agent-based modelling. Addiction (2009) 0.98
Public sentiment towards alcohol and local government alcohol policies in New Zealand. Int J Drug Policy (2011) 0.98
Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia. Med J Aust (2007) 0.97
Know your limits: awareness of the 2009 Australian alcohol guidelines among young people. Drug Alcohol Rev (2011) 0.97
Social demography of alcohol-related harm to children in Australia. Addiction (2012) 0.97
Mechanisms underlying aggressive and hostile behavior in amphetamine users. Curr Opin Psychiatry (2009) 0.96
Better methods to collect self-reported alcohol and other drug use data from Aboriginal and Torres Strait Islander Australians. Drug Alcohol Rev (2014) 0.96
Alcohol consumption and NHMRC guidelines: has the message got out, are people conforming and are they aware that alcohol causes cancer? Aust N Z J Public Health (2014) 0.96
Assessing the wisdom of funding DrinkWise. Med J Aust (2006) 0.95
Increasing socioeconomic inequalities in male cirrhosis of the liver mortality: Australia 1981-2002. Drug Alcohol Rev (2007) 0.95
Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice. Drug Alcohol Rev (2005) 0.92
An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011. Int J Drug Policy (2012) 0.91
The big night out: what happens on the most recent heavy drinking occasion among young Victorian risky drinkers? Drug Alcohol Rev (2014) 0.91
Time of Day and Day of Week Trends in EMS Demand. Prehosp Emerg Care (2015) 0.90
Alcohol consumption over time and risk of death: a systematic review and meta-analysis. Am J Epidemiol (2014) 0.89
Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduct J (2005) 0.88
Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events. J Subst Abuse Treat (2008) 0.88
The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia. Int J Drug Policy (2010) 0.87
Methamphetamine precursor regulation: are we controlling or diverting the drug problem? Addiction (2008) 0.87
'Something's brewing': The changing trends in alcohol coverage in Australian newspapers 2000-2011. Alcohol Alcohol (2013) 0.85
A prospective study of methamphetamine use as a predictor of high school non-attendance in Cape Town, South Africa. Subst Abuse Treat Prev Policy (2010) 0.85
Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified. Drug Alcohol Rev (2007) 0.85
The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting. Resuscitation (2005) 0.84
The impact of khat use on East African communities in Melbourne: a preliminary investigation. Drug Alcohol Rev (2011) 0.84
Breakingtheice: a protocol for a randomised controlled trial of an internet-based intervention addressing amphetamine-type stimulant use. BMC Psychiatry (2012) 0.83
Who suggests drinking less? Demographic and national differences in informal social controls on drinking. J Stud Alcohol Drugs (2013) 0.83
The impacts of others' drinking on mental health. Med J Aust (2011) 0.83
High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia. Addiction (2014) 0.83
Differences between men and women in the course of opiate dependence: is there a telescoping effect? Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia. Drug Alcohol Rev (2009) 0.82
Checkered Expectations: Predictors of Approval of Opening a Casino in the Niagara Community. J Gambl Stud (1999) 0.82
Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration. J Urban Health (2008) 0.82
Contributions of social science to the alcohol field in an era of biomedicalization. Soc Sci Med (2005) 0.82
Comparing short versions of the AUDIT in a community-based survey of young people. BMC Public Health (2013) 0.82
Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia. Drug Alcohol Rev (2007) 0.82
Heavy drinking occasions in Australia: do context and beverage choice differ from low-risk drinking occasions? Drug Alcohol Rev (2014) 0.81
The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving. Drug Alcohol Depend (2003) 0.81
Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing. Drug Alcohol Depend (2011) 0.81
Characteristics of medication overdose presentations to the ED: how do they differ from illicit drug overdose and self-harm cases? Emerg Med J (2010) 0.81